The nurse is caring for an 18-year-old client who has recently been prescribed montelukast. Which statement made by the client indicates understanding of the newly prescribed medication?
"This medication has a tendency to produce anaphylaxis."
"Bloodwork is required regularly to monitor the therapeutic levels of this medication."
"This medication is for long-term treatment for asthma."
"I can repeat this medication twice prior to seeking medical attention."
The Correct Answer is C
A. Anaphylaxis is not a common side effect of montelukast.
B. Regular blood monitoring is not required with montelukast.
C. Montelukast is a leukotriene receptor antagonist, used for long-term management of asthma and to prevent exercise-induced bronchoconstriction.
D. Montelukast is not intended for immediate relief or repeated dosing in acute situations.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. Monitoring heart rate for bradycardia is not a primary concern with cyclobenzaprine; instead, it can cause drowsiness and sedation.
B. Naloxone is not necessary for cyclobenzaprine overdose, as it is not an opioid.
C. Cyclobenzaprine can cause sedation and impair cognitive function, so the nurse should emphasize that clients should not operate heavy machinery or motor vehicles until they know how the medication affects them.
D. Excessive salivation is not a common side effect of cyclobenzaprine; instead, dry mouth is more frequently reported.
Correct Answer is D
Explanation
A. Epinephrine is primarily used for anaphylaxis and severe asthma attacks; it is not effective in reversing opioid overdose.
B. Protamine is an antidote for heparin, not for opioid overdose.
C. Flumazenil is a benzodiazepine antagonist and is not indicated for opioid overdose; it can potentially precipitate seizures in patients with mixed drug overdoses.
D. Naloxone is an opioid antagonist specifically indicated for reversing the effects of opioid overdose, including respiratory depression, making it the appropriate choice in this scenario.